SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Alison M. Pearce, Paul Hanly, Aileen Timmons, Paul M. Walsh, Ciaran O’Neill, Eleanor O’Sullivan, Rachael Gooberman-Hill, Audrey Alforque Thomas, Pamela Gallagher, Linda Sharp, Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches, Applied Health Economics and Health Policy, 2015,

    CrossRef

  2. You have free access to this content2
    Jacqueline W. Miller, Vivien Hanson, Gale D. Johnson, Janet E. Royalty, Lisa C. Richardson, From cancer screening to treatment: Service delivery and referral in the National Breast and Cervical Cancer Early Detection Program, Cancer, 2014, 120, S16
  3. 3
    Donatus U. Ekwueme, Gery P. Guy, Sun Hee Rim, Arica White, Ingrid J. Hall, Temeika L. Fairley, Hazel D. Dean, Health and Economic Impact of Breast Cancer Mortality in Young Women, 1970–2008, American Journal of Preventive Medicine, 2014, 46, 1, 71

    CrossRef

  4. 4
    Paul Hanly, Alison Pearce, Linda Sharp, The cost of premature cancer-related mortality: a review and assessment of the evidence, Expert Review of Pharmacoeconomics & Outcomes Research, 2014, 14, 3, 355

    CrossRef

  5. 5
    Tami L. Thomas, Ora Strickland, Ralph Diclemente, Melinda Higgins, An Opportunity for Cancer Prevention During Preadolescence and Adolescence: Stopping Human Papillomavirus (HPV)-Related Cancer Through HPV Vaccination, Journal of Adolescent Health, 2013, 52, 5, S60

    CrossRef

  6. 6
    Wolf Heitland, Peter K. Schädlich, Xiaoyu Chen, Vanessa Rémy, Lionel Moro, Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany, Journal of Medical Economics, 2013, 16, 3, 364

    CrossRef

  7. 7
    Gerardus W.J. Frederix, Nuz Quadri, Anke M. Hövels, Fleur T. van de Wetering, Hans Tamminga, Jan H.M. Schellens, Andrew J. Lloyd, Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden, Clinical Therapeutics, 2013, 35, 4, e1

    CrossRef

  8. You have free access to this content8
    T. Bärnighausen, D. E. Bloom, E. T. Cafiero, J. C. O’Brien, Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus, Clinical Microbiology and Infection, 2012, 18,
  9. 9
    Diarmuid Coughlan, Kevin D. Frick, Economic Impact of Human Papillomavirus–Associated Head and Neck Cancers in the United States, Otolaryngologic Clinics of North America, 2012, 45, 4, 899

    CrossRef

  10. 10
    Ruth Gil-Prieto, Pablo Viguera Ester, Alejandro Álvaro-Meca, María San Martín Rodríguez, Angel Gil de Miguel, The burden of hospitalizations for anus and penis neoplasm in Spain (1997–2008), Human Vaccines & Immunotherapeutics, 2012, 8, 2, 201

    CrossRef

  11. 11
    Gerardus W.J. Frederix, Nuz Quadri, Anke M. Hovels, Fleur T. van de Wetering, Hans Tamminga, Jan H.M. Schellens, Andrew J. Lloyd, WITHDRAWN: Utility and Work Productivity Data for Economic Evaluation of Breast Cancer Therapies in the Netherlands and Sweden, Health Outcomes Research in Medicine, 2012,

    CrossRef

  12. 12
    Donatus U. Ekwueme, Gery P. Guy, Chunyu Li, Sun Hee Rim, Pratibha Parelkar, Suephy C. Chen, The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006, Journal of the American Academy of Dermatology, 2011, 65, 5, S133.e1

    CrossRef

  13. 13
    Maria A de Peuter, Kavi J Littlewood, Lieven Annemans, Nathalie Largeron, Sibilia Quilici, Cost–effectiveness of catch-up programs in human papillomavirus vaccination, Expert Review of Vaccines, 2010, 9, 10, 1187

    CrossRef

  14. 14
    Tami L. Thomas, Dionne P. Stephens, Beverlee Blanchard, Hip Hop, Health, and Human Papilloma Virus (HPV): Using Wireless Technology to Increase HPV Vaccination Uptake, The Journal for Nurse Practitioners, 2010, 6, 6, 464

    CrossRef

  15. 15
    N.P. Nguyen, A. Chi, L.M. Nguyen, B.H. Ly, U. Karlsson, V. Vinh-Hung, Human papillomavirus-associated oropharyngeal cancer: a new clinical entity, QJM, 2010, 103, 4, 229

    CrossRef

  16. 16
    Chunyu Li, Donatus U. Ekwueme, Sun Hee Rim, Florence K. Tangka, Years of Potential Life Lost and Productivity Losses From Male Urogenital Cancer Deaths—United States, 2004, Urology, 2010, 76, 3, 528

    CrossRef

  17. 17
    Mona Saraiya, Faruque Ahmed, Mary White, Herschel Lawson, Elizabeth R. Unger, Christie Eheman, Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US, Cancer, 2008, 113, S10